Investigator
Robert F. Schwabe
COLUMBIA UNIVERSITY HEALTH SCIENCES · funded by NCI, NIDDK
- Companies
- 1
- Grants
- 6
- Non-dilutive funding
- $4.0M
- First award
- Jul 20, 2021
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Dec 15, 2024.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE78momentum
OncologyPhase II
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Understanding and Targeting Transcriptional Master Regulators in Hepatocellular Carcinoma
$655kDec 15, 2024NCICOLUMBIA UNIVERSITY HEALTH SCIENCESNIH RePORTER · 11247975 (opens the source filing in a new tab)
- P30
The Columbia University Digestive and Liver Disease Research Center
$1.2MApr 30, 2022NIDDKCOLUMBIA UNIVERSITY HEALTH SCIENCESNIH RePORTER · 11085160 (opens the source filing in a new tab)
- P30
The Administrative Core
$246kApr 30, 2022NIDDKCOLUMBIA UNIVERSITY HEALTH SCIENCESNIH RePORTER · 11085162 (opens the source filing in a new tab)
- P30
The Administrative Core
$245kApr 30, 2022NIDDKCOLUMBIA UNIVERSITY HEALTH SCIENCESNIH RePORTER · 11394245 (opens the source filing in a new tab)
- P30
The Columbia University Digestive and Liver Disease Research Center
$1.2MApr 30, 2022NIDDKCOLUMBIA UNIVERSITY HEALTH SCIENCESNIH RePORTER · 11394244 (opens the source filing in a new tab)
- R01
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC
$500kJul 20, 2021NCICOLUMBIA UNIVERSITY HEALTH SCIENCESNIH RePORTER · 11127598 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources